Is Your Depression "Treatment-Resistant" or Just Undertreated?
Feel like your antidepressants aren't working? You might not have Treatment-Resistant Depression. You might just be undertreated. Learn the difference and how to get the right help.
____________________________________________________________________________________
There is a specific kind of exhaustion that comes from trying to heal without results.
You finally gathered the courage to ask for help. You started medication. You waited the 4-6 weeks for it to kick in. And… nothing happened. Or maybe you felt a little better for a month and then slipped back down.
When this happens repeatedly, patients often get slapped with a scary-sounding label: Treatment-Resistant Depression (TRD).
But at NBCG, we often find that the story is more complex. While true treatment resistance is real, many patients we see aren't resistant—they are undertreated or misdiagnosed.
If you feel like you are "failing" treatment, here is how to tell if you’ve hit a wall, or if you’ve just been on the wrong path.
____________________________________________________________________________________
What is True Treatment Resistant Depression?
In the clinical world, "Treatment-Resistant Depression" has a specific definition. Generally, you are considered to have TRD if you have:
Tried at least two different antidepressants.
Taken them at the therapeutic dose (the right strength).
Taken them for adequate duration (usually 6+ weeks).
...and still haven't seen any significant improvement.
If this describes you, it isn't your fault. It simply means your depression may not be driven primarily by serotonin, and you may need advanced treatments like Spravato (esketamine) or TMS Therapy that target different pathways in the brain.
____________________________________________________________________________________
The "Undertreated" Trap: Why Meds Fail
"Undertreated" depression looks exactly like resistant depression, but the cause is different. The medication could work, but it hasn't been given a fair fight.
Here are the most common reasons we see for undertreated depression:
1. The "Sub-Therapeutic" Dose
Many general practitioners start patients on a low dose to minimize side effects but never increase it to a level that actually treats the brain. If you are taking a "starter dose" for months without relief, your depression isn't resisting the treatment; it’s just ignoring it.
The Fix: Expert Medication Management. Our psychiatrists carefully titrate your dose to find the "sweet spot"—maximum relief with minimum side effects.
2. The Wrong Diagnosis (The "Mimics")
Depression is often a symptom of something else. If you are treating depression, but the root cause is ADHD, Anxiety, or Bipolar II, standard antidepressants might do nothing—or even make you feel worse.
The Fix: Psychological & Neurological Testing. We don’t guess; we test. By evaluating ADHD, processing disorders, or mood cycling, we ensure we are treating the right condition.
3. Metabolic Factors
Your DNA determines how fast your liver breaks down medication. If you are a "rapid metabolizer," you might be digesting your antidepressant so fast that it never reaches your brain. Conversely, "slow metabolizers" may experience intense side effects even on low doses.
The Fix: Advanced Pharmacogenomic (PGx) Testing We use industry-leading genetic panels to take the guesswork out of your prescription:
GeneSight®: This test analyzes how your specific genes may affect your outcomes with medications for depression, anxiety, and ADHD. It categorizes medications into a "color-coded" report to show which ones may be more effective or cause fewer side effects for you.
Tempus: For an even deeper dive, we offer Tempus testing. Tempus combines genetic sequencing with AI-driven clinical data. It not only looks at your DNA but also provides our clinicians with evidence-based "gene-drug" interactions and a mobile app (Tempus PRO™) to track your real-time response to new medications.
4. The " Pseudo-Resistance" of Lifestyle
Medication is a bridge, not a teleporter. If you are taking medication but struggling with untreated sleep apnea, severe vitamin deficiencies, or chronic high stress, the medication has to work overtime just to keep you afloat.
The Fix: A Whole-Person Approach. We look at your blood work, your sleep, and your therapy needs to ensure your body is physically capable of healing.
____________________________________________________________________________________
So, Which One Is It?
If you have tried "everything" and still feel stuck, ask yourself these three questions:
Did I stay on my medication for at least 8 weeks?
Did my doctor ever adjust the dose, or did we stay on the starting amount?
Have I had a comprehensive evaluation to rule out ADHD, Bipolar Disorder, or other medical issues?
____________________________________________________________________________________
How We Can Help
At NBCG, we specialize in untangling these complex cases. We don’t just write a refill and send you on your way.
If you are Undertreated: Our medication management team will refine your regimen, using genetic testing and precise dosing to get you back on track.
If you are Treatment-Resistant: We offer the advanced services you need, such as Spravato (esketamine) and other interventional treatments designed specifically for stubborn depression.
You are not "broken", and you are not out of options. You might just need a different map.
____________________________________________________________________________________
NBCG Contact Information
Get a Second Opinion That Matters.
Don't settle for partial relief. Whether you need a comprehensive diagnostic evaluation, advanced depression services, or expert medication management, our team is ready to listen.
Call us to schedule an evaluation: (801) 760-4581
Explore our depression services: www.neurobcg.com
Follow us on Instagram or Facebook for treatment options and patient education events.
____________________________________________________________________________________
References:
American Psychiatric Association. (2023). Clinical Practice Guideline for the Treatment of Depression.
Cleveland Clinic. (2024). Treatment-Resistant Depression: Causes, Symptoms, and Management.
Thase, Michael E, et al. (2019). Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications with Gene-Drug Interactions in a Randomized Controlled Trial. Journal of clinical psychiatry vol. 80. (Supporting GeneSight/Tempus utility).
Mayo Clinic. (2021). Treatment-resistant Depression.
Tempus Labs. (2025). Clinical Utility of Pharmacogenomics in Psychiatric Care. [Technical Whitepaper].

